Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Vaccine|June 14, 2017
Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelersRadboud J Duintjer Tebbens, Kimberly M ThompsonBMC Infectious Diseases|September 19, 2015
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmissionKimberly M Thompson, Radboud J Duintjer TebbensMedscape Journal of Medicine|October 18, 2008
The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessationKimberly M Thompson, Radboud J Duintjer TebbensRisk Analysis : an Official Publication of the Society for Risk Analysis|August 12, 2014
Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting ExamplesKimberly M Thompson, Radboud J Duintjer TebbensBMC Infectious Diseases|September 19, 2015
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypesKimberly M Thompson, Radboud J Duintjer TebbensLancet (London, England)|April 24, 2007
Eradication versus control for poliomyelitis: an economic analysisKimberly M Thompson, Radboud J Duintjer TebbensExpert Review of Vaccines|July 31, 2018
Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccineRadboud J Duintjer Tebbens, Kimberly M ThompsonExpert Review of Vaccines|April 25, 2017
Poliovirus vaccination during the endgame: insights from integrated modelingRadboud J Duintjer Tebbens, Kimberly M ThompsonRisk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Retrospective cost-effectiveness analyses for polio vaccination in the United StatesKimberly M Thompson, Radboud J Duintjer TebbensExpert Review of Vaccines|December 7, 2013
National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradicationKimberly M Thompson, Radboud J Duintjer TebbensPageof 17